Boehringer Makes Case For Interchangeable Adalimumab Biosimilar

Voltaire-X Switching Study Concludes Similar Clinical Outcomes

 
• By Dean Rudge
boehringer hq
AbbVie believes two Humira biosimilars will be designated interchangeable with Humira • Source: Shutterstock

More from Biosimilars

More from Products